[저널] Health Policy // Volume 117, Issue 3 , Pages 275-420, September 2014 Editorial Board /Pages iii Contents /Pages iv-v >> Health reform monitor Indicators of health system coverage and activity in Ireland during the economic crisis 2008–2014 – From ‘more with less’ to ‘less with less’ Pages 275-278 Sara Burke, Steve Thomas, Sarah Barry, Conor Keegan Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece Original Research Article Pages 279-284 Ilias Goranitis, Olga Siskou, Lycourgos Liaropoulos >> Pharmaceutical policies and their impact Interventions promoting the acceptance and uptake of generic medicines: A narrative review of the literature Review Article Pages 285-296 Z.U.D. Babar, S.W. Kan, S. Scahill Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review Review Article Pages 297-310 Mohamed Azmi Hassali, Zhi Yen Wong, Alian A. Alrasheedy, Fahad Saleem, Abdul Haniff Mohamad Yahaya, Hisham Aljadhey Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries Original Research Article Pages 311-327 Sabine Vogler, Katharina Habimana, Danielle Arts Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe Original Research Article Pages 328-333 Paola Minghetti, Doriana Pantano, Chiara Grazia Milena Gennari, Antonella Casiraghi Evaluation of a possible predictor for Federal Joint Committee decisions on early benefit assessments according to the German act on the reform of the market for medicinal products Original Research Article Pages 334-344 Björn Schwander, Kurt Banz, Klaus Kaier, Stefan Walzer Managed entry agreements for pharmaceuticals in Australia Original Research Article Pages 345-352 Agnes Vitry, Elizabeth Roughead Druggists and pharmacists as gatekeepers: Sales routines and compliance with sales protocols for over-the-counter naproxen 275 mg medicines in the Netherlands Original Research Article Pages 353-360 Joris J. van Hoof, Michel H.G. Cents, Nicole M.J. Megens, Sijbrand J. van der Tang The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010 Original Research Article Pages 361-373 Frank R. Lichtenberg, Mehtap Tatar, Zafer Çalışkan Medication supply, healthcare outcomes and healthcare expenses: Longitudinal analyses of patients with type 2 diabetes and hypertension Original Research Article Pages 374-381 Chi-Chen Chen, Robert H. Blank, Shou-Hsia Cheng >> Health research policies The international spread of Academic Health Science Centres: A scoping review and the case of policy transfer to England Review Article Pages 382-391 Catherine E. French, Ewan Ferlie, Naomi J. Fulop The Ontario Drug Policy Research Network: Bridging the gap between Research and Drug Policy Original Research Article Pages 392-398 Sobia Khan, Julia E. Moore, Tara Gomes, Ximena Camacho, Judy Tran, Glenn McAuley, David N. Juurlink, Michael Paterson, Andreas Laupacis, Muhammad M. Mamdani Partners in projects: Preparing for public involvement in health and social care research Original Research Article Pages 399-408 Jacqueline H. Parkes, Michelle Pyer, Paula Wray, Jane Taylor How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives Review Article Pages 409-420 Annette Rid
Posted on: Wed, 10 Sep 2014 03:50:03 +0000
Trending Topics
Recently Viewed Topics
© 2015